Mereo BioPharma Group PLCNASDAQ:MREO
- LAST PRICE3.6800
- TODAY'S CHANGE (%)0.1000 (2.7933%)
- Bid / Lots---/ ---
- Ask / Lots---/ ---
- Open / Previous Close3.6000 / 3.5800
- Day Range
- 52 Week Range
- Volume864,936
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | MREO |
|---|---|---|
| 09:32 ET | 5028 | 3.52 |
| 09:33 ET | 200 | 3.65 |
| 09:35 ET | 10091 | 3.555 |
| 09:37 ET | 1000 | 3.5201 |
| 09:39 ET | 100 | 3.55 |
| 09:44 ET | 1000 | 3.54 |
| 09:46 ET | 3522 | 3.56 |
| 09:48 ET | 8691 | 3.59 |
| 09:50 ET | 5856 | 3.56 |
| 09:51 ET | 8184 | 3.6 |
| 09:53 ET | 6400 | 3.57 |
| 09:55 ET | 3300 | 3.565 |
| 09:57 ET | 8221 | 3.57 |
| 10:00 ET | 5600 | 3.54 |
| 10:02 ET | 400 | 3.55 |
| 10:04 ET | 11700 | 3.55 |
| 10:06 ET | 200 | 3.54 |
| 10:08 ET | 4700 | 3.535 |
| 10:09 ET | 200 | 3.535 |
| 10:11 ET | 3700 | 3.55 |
| 10:13 ET | 200 | 3.545 |
| 10:15 ET | 1600 | 3.555 |
| 10:18 ET | 3976 | 3.55 |
| 10:20 ET | 1000 | 3.57 |
| 10:24 ET | 1773 | 3.575 |
| 10:26 ET | 2600 | 3.595 |
| 10:27 ET | 400 | 3.595 |
| 10:29 ET | 5781 | 3.585 |
| 10:31 ET | 500 | 3.57 |
| 10:33 ET | 2454 | 3.56 |
| 10:36 ET | 2218 | 3.57 |
| 10:38 ET | 1531 | 3.585 |
| 10:40 ET | 100 | 3.585 |
| 10:42 ET | 100 | 3.5891 |
| 10:45 ET | 575 | 3.59 |
| 10:47 ET | 100 | 3.585 |
| 10:49 ET | 3702 | 3.57 |
| 10:51 ET | 2326 | 3.57 |
| 10:56 ET | 2013 | 3.58 |
| 10:58 ET | 100 | 3.575 |
| 11:02 ET | 3600 | 3.605 |
| 11:03 ET | 1600 | 3.605 |
| 11:05 ET | 5353 | 3.6 |
| 11:07 ET | 3900 | 3.605 |
| 11:09 ET | 3959 | 3.59 |
| 11:12 ET | 1000 | 3.58 |
| 11:14 ET | 900 | 3.58 |
| 11:16 ET | 4200 | 3.585 |
| 11:18 ET | 800 | 3.58 |
| 11:20 ET | 200 | 3.58 |
| 11:21 ET | 700 | 3.585 |
| 11:23 ET | 1000 | 3.585 |
| 11:25 ET | 2265 | 3.61 |
| 11:27 ET | 1326 | 3.605 |
| 11:30 ET | 938 | 3.605 |
| 11:32 ET | 1424 | 3.61 |
| 11:34 ET | 33272 | 3.61 |
| 11:36 ET | 1917 | 3.635 |
| 11:38 ET | 3800 | 3.6 |
| 11:39 ET | 1450 | 3.615 |
| 11:41 ET | 800 | 3.61 |
| 11:43 ET | 500 | 3.615 |
| 11:45 ET | 300 | 3.615 |
| 11:48 ET | 200 | 3.61 |
| 11:50 ET | 18371 | 3.625 |
| 11:52 ET | 300 | 3.62 |
| 11:54 ET | 1276 | 3.625 |
| 11:56 ET | 300 | 3.625 |
| 11:57 ET | 500 | 3.625 |
| 11:59 ET | 3884 | 3.625 |
| 12:01 ET | 2795 | 3.625 |
| 12:03 ET | 3587 | 3.64 |
| 12:06 ET | 400 | 3.635 |
| 12:08 ET | 1100 | 3.635 |
| 12:10 ET | 100 | 3.635 |
| 12:12 ET | 2084 | 3.64 |
| 12:14 ET | 550 | 3.635 |
| 12:15 ET | 5002 | 3.62 |
| 12:17 ET | 1400 | 3.625 |
| 12:19 ET | 1998 | 3.62 |
| 12:21 ET | 400 | 3.62 |
| 12:24 ET | 400 | 3.625 |
| 12:28 ET | 400 | 3.625 |
| 12:30 ET | 926 | 3.62 |
| 12:32 ET | 550 | 3.625 |
| 12:33 ET | 842 | 3.625 |
| 12:35 ET | 697 | 3.625 |
| 12:37 ET | 1000 | 3.6259 |
| 12:39 ET | 100 | 3.63 |
| 12:42 ET | 2875 | 3.64 |
| 12:44 ET | 11010 | 3.64 |
| 12:46 ET | 3223 | 3.645 |
| 12:50 ET | 5000 | 3.655 |
| 12:51 ET | 200 | 3.655 |
| 12:53 ET | 4200 | 3.665 |
| 12:55 ET | 250 | 3.664732 |
| 12:57 ET | 300 | 3.665 |
| 01:00 ET | 3491 | 3.655 |
| 01:02 ET | 900 | 3.655 |
| 01:04 ET | 1811 | 3.67 |
| 01:06 ET | 5798 | 3.665 |
| 01:08 ET | 3615 | 3.6711 |
| 01:09 ET | 300 | 3.675 |
| 01:15 ET | 100 | 3.675 |
| 01:18 ET | 726 | 3.675 |
| 01:24 ET | 800 | 3.6793 |
| 01:26 ET | 4956 | 3.67 |
| 01:27 ET | 2618 | 3.67 |
| 01:29 ET | 1300 | 3.665 |
| 01:31 ET | 400 | 3.665 |
| 01:36 ET | 5419 | 3.635 |
| 01:38 ET | 1000 | 3.635 |
| 01:40 ET | 2799 | 3.6325 |
| 01:42 ET | 752 | 3.645 |
| 01:44 ET | 126 | 3.645 |
| 01:45 ET | 100 | 3.645 |
| 01:47 ET | 4388 | 3.64 |
| 01:49 ET | 100 | 3.64 |
| 01:54 ET | 3473 | 3.63 |
| 01:56 ET | 9732 | 3.64 |
| 01:58 ET | 6563 | 3.645 |
| 02:00 ET | 1200 | 3.645 |
| 02:02 ET | 1200 | 3.645 |
| 02:03 ET | 2540 | 3.645 |
| 02:05 ET | 1258 | 3.645 |
| 02:07 ET | 900 | 3.645 |
| 02:09 ET | 2692 | 3.63 |
| 02:12 ET | 100 | 3.635 |
| 02:14 ET | 100 | 3.63 |
| 02:18 ET | 300 | 3.63 |
| 02:20 ET | 1766 | 3.625 |
| 02:21 ET | 300 | 3.625 |
| 02:23 ET | 1000 | 3.625 |
| 02:25 ET | 2003 | 3.625 |
| 02:30 ET | 6383 | 3.625 |
| 02:32 ET | 600 | 3.625 |
| 02:34 ET | 4732 | 3.625 |
| 02:36 ET | 4104 | 3.635 |
| 02:38 ET | 400 | 3.635 |
| 02:39 ET | 100 | 3.6325 |
| 02:41 ET | 5539 | 3.635 |
| 02:43 ET | 6950 | 3.645 |
| 02:45 ET | 15741 | 3.625 |
| 02:48 ET | 400 | 3.6225 |
| 02:50 ET | 5110 | 3.62 |
| 02:52 ET | 4981 | 3.625 |
| 02:54 ET | 2604 | 3.625 |
| 02:56 ET | 926 | 3.625 |
| 02:57 ET | 800 | 3.6216 |
| 02:59 ET | 4378 | 3.62 |
| 03:01 ET | 600 | 3.615 |
| 03:03 ET | 1452 | 3.615 |
| 03:06 ET | 326 | 3.62 |
| 03:08 ET | 4000 | 3.63 |
| 03:10 ET | 3137 | 3.635 |
| 03:12 ET | 1100 | 3.64 |
| 03:15 ET | 12891 | 3.645 |
| 03:17 ET | 5794 | 3.645 |
| 03:19 ET | 1926 | 3.6425 |
| 03:21 ET | 600 | 3.645 |
| 03:26 ET | 100 | 3.645 |
| 03:28 ET | 850 | 3.6425 |
| 03:30 ET | 9143 | 3.665 |
| 03:32 ET | 4000 | 3.665 |
| 03:33 ET | 4338 | 3.665 |
| 03:35 ET | 24508 | 3.665 |
| 03:37 ET | 3894 | 3.6625 |
| 03:39 ET | 2431 | 3.665 |
| 03:42 ET | 1400 | 3.665 |
| 03:44 ET | 3900 | 3.665 |
| 03:46 ET | 9722 | 3.665 |
| 03:48 ET | 5663 | 3.66 |
| 03:50 ET | 6994 | 3.66 |
| 03:51 ET | 8415 | 3.66 |
| 03:53 ET | 15215 | 3.665 |
| 03:55 ET | 10122 | 3.6747 |
| 03:57 ET | 17517 | 3.68 |
| 04:00 ET | 69637 | 3.68 |
Nov 14, 2024
Mereo BioPharma to Participate in Fireside Chat at the Jefferies London Healthcare Conference, from 7:30AM ET on Thursday Nov 14, 2024 by Dow Jones
7:30AM ET on Thursday Nov 14, 2024 by Dow Jones
Nov 12, 2024
DJ Mereo BioPharma Group Price Target Maintained With a $7.00/Share by Needham, from 12:35PM ET on Tuesday Nov 12, 2024 by Dow Jones
12:35PM ET on Tuesday Nov 12, 2024 by Dow JonesMereo BioPharma Reports Third Quarter 2024 Financial Results and Provides Corporate Update, from 7:30AM ET on Tuesday Nov 12, 2024 by Dow Jones
7:30AM ET on Tuesday Nov 12, 2024 by Dow JonesPress Release: Mereo BioPharma Reports Third Quarter 2024 Financial Results and Provides Corporate Update, from 7:30AM ET on Tuesday Nov 12, 2024 by Dow Jones
7:30AM ET on Tuesday Nov 12, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Mereo BioPharma Group PLC | 550.8M | 0.0x | --- |
Kezar Life Sciences Inc | 546.5M | -0.6x | --- |
Immunome Inc | 581.1M | -1.6x | --- |
Stoke Therapeutics Inc | 599.1M | -5.4x | --- |
Humacyte Inc | 551.4M | -3.3x | --- |
Mind Medicine (MindMed) Inc | 551.5M | -3.6x | --- |
Company Information
Mereo BioPharma Group plc is a biopharmaceutical company focused on the development of therapeutics for rare diseases. The Company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat primarily for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD). In addition to the rare disease programs, it has two oncology product candidates in clinical development. Etigilimab is an IgG1 monoclonal antibody which binds to the human T-cell immunoreceptor with Ig and ITIM domains (TIGIT) receptor on immune cells to improve the activation and effectiveness of T-cell and NK cell antitumor activity. Navicixizumab is a bispecific antibody that inhibits delta-like ligand 4 (DLL4) and vascular endothelial growth factor (VEGF). Navicixizumab is developed for the treatment of late line ovarian cancer.
Contact Information
- Headquarters
- One Cavendish Place, Fourth FloorLONDON, United Kingdom W1G0QF
- Phone
- ---
- Fax
- ---
Executives
- Non-Executive Independent Director
- Michael Wyzga
- Chief Executive Officer, Director
- Denise Scots-Knight
- Chief Financial Officer
- Christine Fox
- Chief Scientific Officer
- John Lewicki
- General Counsel and Business Development, Company Secretary
- Charles Sermon
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $566.2M |
|---|---|
Revenue (TTM) | --- |
Shares Outstanding | 153.9M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.97 |
EPS | --- |
Book Value | $0.36 |
P/E Ratio | 0.0x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
